Pidlilite Industries shares rose as much as 2% to reach an intraday high of ₹1,488.90 per equity share on the NSE on Friday, October 9, 2026. The rally followed the board of directors’ approval of Amith Agarwal as Chief Financial Officer and Senior Management Personnel effective October 9, 2026. The appointment was confirmed through a Circular Resolution passed on the same day, as disclosed in a regulatory filing. The move coincided with a broader market lift, with the Indian benchmark indices trading in deep green during the afternoon session.

The SENSEX surged as much as 1.27% to hit an intraday high of 72,502.92, while the NIFTY50 climbed as much as 1.36% to touch a session peak of 22,534.40. At 1:27 PM, the S&P BSE SENSEX rose 851.45 points, or 1.19%, to 72,444.69, and the NSE’s NIFTY50 stood at 22,505.10, up 273.30 points, or 1.23%. Investor sentiment improved amid a decline in global crude oil prices, easing US bond yields, and strong global cues.

The NIFTY50 index was led by ITC Ltd, Tata Consultancy Services (TCS), Apollo Hospitals Enterprise, Eicher Motors, Adani Ports and Special Economic Zones, and Shriram Finance, which were among the top gainers. Conversely, BSE, Reliance Industries Ltd (RIL), and JSW Steel were the only three constituents of the NIFTY50 index that were trading in the red. IT stocks such as TCS, Infosys, HCL Tech, and Mphasis rallied after the opening bell, buoyed by a US green card programme suspension update that did not impact Indian firms.

TCS stock gained as much as 6.16% to hit an intraday high of ₹2,204 per equity share on the NSE, following the company’s Q2 results. TCS reported a 15% jump in net profit to ₹13,884 crore and an 11.22% rise in revenue from operations to ₹73,188 crore in the July-September period. The company’s earnings were broadly in line with or exceeded expectations on key parameters, and the US government’s decision to suspend the PERM programme added to the positive sentiment.

Pharma and hospital stocks such as Sun Pharmaceutical, Dr Reddy’s Laboratories, Max Healthcare Institute, Fortis Healthcare, Apollo Hospitals, and Global Health (Medanta) surged on Friday, October 9, as uncertainty eased after the Department of Pharmaceuticals announced a 30% trade margin cap on non‑scheduled anti‑cancer drugs. The measure will cover 110 medicines, including 35 patented drugs, and is expected to be implemented later this month, according to PTI reports.

Other notable moves included Hexaware Technologies stock surging 12.3% to ₹574.50 after announcing a multi‑year partnership with Anthropic, and Pace Digitek shares jumping 6% to ₹171.56 after securing a ₹179.4 crore order from BSES Rajdhani Power Limited for a 57.5 MW/115 MWh battery energy storage system. NCC Ltd shares rose 6.5% to ₹127.74 after winning a ₹1,286.03 crore order from Hyderabad Growth Corridor Ltd for a radial road construction project.